FLUOPTICS reçoit l’autorisation de mise sur le marché de la FDA pour son Fluobeam®pour la détection en temps réel de parathyroide durant la chirurgie.
November 12, 2018
FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery. The FLUOBEAM® Imaging System becomes the first and unique system certified for this indication.
The FLUOBEAM® provides, earlier, real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands). The early detection of theses glands allows reduces postoperative hypocalcemia.